Shanghai Hile Bio-Technology announced that the company plans to sell 76.07% equity of Yangling Jinhai held by its controlling shareholder Shanghai Haoyuan. After the completion of this transaction, the company will no longer hold equity in Yangling Jinhai directly, and Yangling Jinhai will no longer be included in the company's consolidated financial statements; in addition, the company will recover all loans to Yangling Jinhai and repay relevant bank loans.
海利生物：拟向控股股东上海豪园出售杨凌金海76.07%股权
Shanghai Hile Bio-Technology: Intends to sell 76.07% equity of Yangling Jin Hai to its controlling shareholder Shanghai Haoyuan.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated